2017
DOI: 10.1002/term.2563
|View full text |Cite
|
Sign up to set email alerts
|

Fabrication of a biomimetic ZeinPDA nanofibrous scaffold impregnated with BMP‐2 peptide conjugated TiO 2 nanoparticle for bone tissue engineering

Abstract: A biomimetic Zein polydopamine based nanofiber scaffold was fabricated to deliver bone morphogenic protein-2 (BMP-2) peptide conjugated titanium dioxide nanoparticles in a sustained manner for investigating its osteogenic differentiation potential. To prolong its retention time at the target site, BMP-2 peptide has been conjugated to titanium dioxide nanoparticles owing to its high surface to volume ratio. The effect of biochemical cues from BMP-2 peptide and nanotopographical stimulation of electrospun Zein p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(16 citation statements)
references
References 38 publications
(38 reference statements)
0
16
0
Order By: Relevance
“…Thus, the bone morphogenetic protein-2 biomimetic peptide (BMPBP) has been proposed considering its reduced size (i.e., between 20 and 30 amino acids) and the presence of typical SSPVT morphogenic sequences. Scaffolds encapsulating BMPBP were able to induce osteogenic differentiation and promote bone tissue regeneration [163,164]. However, these scaffolds could not provide sufficient bioactivity to meet the requirements of clinical application.…”
Section: Hard Tissue Regenerationmentioning
confidence: 99%
“…Thus, the bone morphogenetic protein-2 biomimetic peptide (BMPBP) has been proposed considering its reduced size (i.e., between 20 and 30 amino acids) and the presence of typical SSPVT morphogenic sequences. Scaffolds encapsulating BMPBP were able to induce osteogenic differentiation and promote bone tissue regeneration [163,164]. However, these scaffolds could not provide sufficient bioactivity to meet the requirements of clinical application.…”
Section: Hard Tissue Regenerationmentioning
confidence: 99%
“…A nature-based approach, i.e., biomimetics associated with the adaptation of models inspired by biology, has been the basis for the generation of new systems or materials ( 15 ). The tendency to form IAPP-amyloid structures of hundreds of organisms has not been completely analyzed.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, that of OCPcolTPTDf 0.1 or β‐TCPcolTPTDf 0.1 demonstrated about one‐quarter of the TPTD was released within 7 days, and three‐quarters remained at 28 days. These results resembled the release profile of bone morphogenic protein‐2 (BMP‐2) from Zein polydopamine TiO2 BMP‐2, which could have triggered early differentiation markers and activated the expression of late osteogenic markers (Babitha et al, ). The release pattern of OCPcolTPTDf or β‐TCPcolTPTDf suggested that TPTD was retained in OCPcol or β‐TCPcol after initial release.…”
Section: Discussionmentioning
confidence: 60%